Education
About Us
Working with TipRanks
Follow Us
Biophytis (BPTSY)
OTHER OTC:BPTSY
BPTSY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.47 - $7.61
Previous CloseN/A
Volume804.00
Average Volume (3M)0.00
Market Cap
$3.33M
Enterprise Value$64.82M
Total Cash (Recent Filing)$2.30M
Total Debt (Recent Filing)€7.19M
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Nov 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15420.51
Shares Outstanding2,211,346
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-3.39
Price to Sales (P/S)0.00
P/FCF Ratio-0.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$15.00Price Target Upside893.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Biophytis News
PremiumCompany Announcements
Biophytis to Showcase Developments at BIO International Convention
PremiumCompany Announcements
Biophytis Postpones 2024 Financial Statement Release
PremiumCompany Announcements
Biophytis Showcases Promising Obesity Treatment at ECO 2025PremiumCompany Announcements
Biophytis Delays Yearly Report Due to Financing Efforts
PremiumCompany Announcements
Biophytis Delays 2024 Financial Statement Publication Due to RefinancingPremiumCompany Announcements
Biophytis Targets Mobility Restoration in Obesity with BIO101PremiumCompany Announcements
Biophytis Launches Phase 2 OBA Clinical Trial in Obesity
PremiumCompany Announcements
Biophytis Completes €2.6 Million Private PlacementBPTSY FAQ
What was Biophytis’s price range in the past 12 months?
Biophytis lowest stock price was $1.47 and its highest was $7.61 in the past 12 months.
What is Biophytis’s market cap?
Biophytis’s market cap is $3.33M.
When is Biophytis’s upcoming earnings report date?
Biophytis’s upcoming earnings report date is Nov 04, 2025 which is in 138 days.
How were Biophytis’s earnings last quarter?
Currently, no data Available
Is Biophytis overvalued?
According to Wall Street analysts Biophytis’s price is currently Undervalued.
Does Biophytis pay dividends?
Biophytis does not currently pay dividends.
What is Biophytis’s EPS estimate?
Biophytis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biophytis have?
Biophytis has 2,211,346 shares outstanding.
What happened to Biophytis’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biophytis?
Currently, no hedge funds are holding shares in BPTSY
Company Description
Biophytis
Biophytis (BPTSY) is a clinical-stage biotechnology company focused on the development of therapeutics aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases. The company's product pipeline includes drug candidates targeting neuromuscular diseases such as sarcopenia and other conditions like severe respiratory failure in COVID-19 patients. Biophytis utilizes its proprietary technology platforms to advance its research and development efforts in these areas.